- Home
- VATE vs PLX Comparison
VATE vs PLX Comparison
Compare VATE & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VATE | PLX |
|---|---|---|
| Founded | 1994 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 168.2M | 159.5M |
| IPO Year | 1996 | 1996 |
Fundamental Metrics
Financial Performance| Metric | VATE | PLX |
|---|---|---|
| Price | $15.28 | $2.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 55.7K | ★ 890.8K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | ★ $1,246,000,000.00 | $52,744,000.00 |
| Revenue This Year | N/A | $36.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.59 |
| Revenue Growth | ★ 12.55 | N/A |
| 52 Week Low | $3.75 | $1.34 |
| 52 Week High | $16.71 | $3.19 |
Technical Indicators
Market Signals| Indicator | VATE | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 66.82 | 52.89 |
| Support Level | $4.48 | $2.06 |
| Resistance Level | N/A | $2.16 |
| Average True Range (ATR) | 1.23 | 0.11 |
| MACD | 0.19 | 0.03 |
| Stochastic Oscillator | 77.92 | 77.05 |
Price Performance
Historical ComparisonAbout VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.